|
Volumn 76, Issue 3, 2002, Pages 234-242
|
Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome
|
Author keywords
Albinism; Pirfenidone; Platelet Storage pool; Pulmonary fibrosis; Vesicle formation
|
Indexed keywords
ANTIFIBROTIC AGENT;
PIRFENIDONE;
ABSCESS;
ADULT;
ANXIETY;
ARTHRALGIA;
ARTICLE;
CAPILLARY RESISTANCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DROWSINESS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
FATIGUE;
FEMALE;
FEVER;
FORCED EXPIRATORY VOLUME;
GASTROINTESTINAL DISEASE;
GENE MUTATION;
HOMOZYGOSITY;
HOSPITAL ADMISSION;
HUMAN;
KIDNEY CYST;
LEG EDEMA;
LUNG FIBROSIS;
LUNG FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
NEPHROLITHIASIS;
OCULAR ALBINISM;
OTALGIA;
PHOTOSENSITIVITY;
PREDICTION;
PRIORITY JOURNAL;
PRURITUS;
PUERTO RICO;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
THORAX PAIN;
TREATMENT OUTCOME;
VERTIGO;
WEIGHT GAIN;
ADULT;
DOUBLE-BLIND METHOD;
FEMALE;
HERMANSKI-PUDLAK SYNDROME;
HUMANS;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PLACEBOS;
PULMONARY FIBROSIS;
PYRIDONES;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
|
EID: 0036376666
PISSN: 10967192
EISSN: None
Source Type: Journal
DOI: 10.1016/S1096-7192(02)00044-6 Document Type: Article |
Times cited : (171)
|
References (28)
|